EP1362091A1 - Method and device for ultrasonic innoculation of biological cell material - Google Patents
Method and device for ultrasonic innoculation of biological cell materialInfo
- Publication number
- EP1362091A1 EP1362091A1 EP02717954A EP02717954A EP1362091A1 EP 1362091 A1 EP1362091 A1 EP 1362091A1 EP 02717954 A EP02717954 A EP 02717954A EP 02717954 A EP02717954 A EP 02717954A EP 1362091 A1 EP1362091 A1 EP 1362091A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- innoculation
- ultrasonic
- cells
- ultrasound
- biological
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 14
- 239000000463 material Substances 0.000 title abstract description 14
- 239000003365 glass fiber Substances 0.000 claims abstract description 11
- 239000012530 fluid Substances 0.000 claims abstract 2
- 238000002604 ultrasonography Methods 0.000 claims description 14
- 239000000835 fiber Substances 0.000 claims description 7
- 238000002847 impedance measurement Methods 0.000 claims 1
- 238000011081 inoculation Methods 0.000 claims 1
- 239000012499 inoculation medium Substances 0.000 claims 1
- 239000002245 particle Substances 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 20
- 230000000144 pharmacologic effect Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 4
- 238000002255 vaccination Methods 0.000 description 4
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 230000000712 assembly Effects 0.000 description 2
- 238000000429 assembly Methods 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 238000004026 adhesive bonding Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
- C12M35/04—Mechanical means, e.g. sonic waves, stretching forces, pressure or shear stimuli
Definitions
- the aim is to develop a method that is as inexpensive and simple as possible in order to inoculate individual cells or cell assemblies with biological molecules and / or pharmaceutical particles.
- the procedure for opening the cell has to be carried out with extremely complex precision technology and therefore the costs for a single cell vaccination are very high.
- one or more individual ultrasound-guiding glass fibers are in a suspension of cells and vaccine material in solution is introduced and excited via suitably coupled electrical or magnetostrictive ultrasound transmitters.
- An arrangement consisting of a piezoelectric composite transducer has proven to be particularly suitable, which together with the glass fiber or the fiber bundle forms an acoustic system which is excited in resonance.
- the sound coupling into the glass fiber or the fiber bundle is advantageously carried out by a mechanical connection such as gluing or clamping at a point where the amplitude of the mechanical tension is minimal (tension node).
- the glass fiber or the fiber bundle must be a multiple of half the wavelength.
- the method for vaccinating individual cells or cell assemblies can also be used for medical applications in such a way that vaccine material is introduced into the target region of a biological tissue via a guide catheter and the ultrasound-guiding glass fiber is introduced via this catheter or a second access and an ultrasound field is then built up in the area of application of the cavitation in the target region to be treated, in order to promote an accelerated vaccination of the target tissue material at the cellular level with biological / genetic engineering or pharmacological material.
- 1 shows an exemplary embodiment consisting of an ultrasound transducer 2 with a device 3 for measuring the amplitude, which may consist, for example, of an additional, passive piezo disk, and the mechanical coupling 4 of the glass fiber 5.
- the ultrasound transducer 2 is generated by the electric ultrasound generator 1 driven, which simultaneously evaluates the signal of the measuring device 3 and regulates the frequency and amplitude in the sense of an optimal effect.
- the distal end of the fiber 5 is in the suspension 7 of the cells and the inoculum in solution, which is located in the reaction vessel 6.
- the cavitation effects 8 caused by the ultrasound in the suspension 7 enable or support the introduction of the biological and or pharmacological material into the cells.
- FIG. 2 shows an embodiment for vaccinating cells in the
- the ultrasound transducer 10 transmits one with an amplitude measuring device 11 and a coupling 12
- Ultrasonic vibration on the flexible glass fiber 13 the ultrasonic transducer 10 by the generator 1, which simultaneously regulates the amplitude and frequency to an optimum value for the effect with the aid of the signal from the measuring device 11.
- the glass fiber 13 leads through a guide catheter 14 into the tissue area 15 to be treated.
- the biological or pharmacological material to be inoculated in solution is injected 16 through the guide catheter 14, which material can penetrate into the cells through the ultrasound effects 17.
Abstract
The invention relates to a method and a device for ultrasonic innoculation of biological cell material. The aim of the invention is to provide a simple method enabling low-cost innoculation of individual cells or cell unions with biological molecules and/or with pharmaceutical particles. This is essentially achieved by bringing the ultrasonic energy used, via suitably formed glass fibers, into the immediate vicinity of the cells to be innoculated in a fluid containing the innoculation medium.
Description
Verfahren und Vorrichtung zur Ultraschall- Impfung von biologischem Zellmaterial Method and device for the ultrasonic vaccination of biological cell material
Aufgabenstellungtask
Es soll ein möglichst preiswertes und einfaches Verfahren entwickelt werden, um einzelne Zellen oder Zellverbände mit biologischen Molekülen und/oder pharmazeutischen Partikeln zu impfen. Stand der TechnikThe aim is to develop a method that is as inexpensive and simple as possible in order to inoculate individual cells or cell assemblies with biological molecules and / or pharmaceutical particles. State of the art
Es ist bekannt, über mechanisch oder optisch gesteuerte Mikromanipulatoren einzelne Zellen mittels Injektionsnadeln und/oder Laserstrahlen punktuell zu eröffnen und über die so geschaffenen Kanäle biologisches oder pharmazeutisches Material in die Zellen einzuschleusen. Hierzu gibt es eine Vielzahl von Veröffentlichungen und Patentanmeldungen, die dem interessierten Fachmann bekanntIt is known to selectively open individual cells by means of injection needles and / or laser beams via mechanically or optically controlled micromanipulators and to introduce biological or pharmaceutical material into the cells via the channels thus created. There are a large number of publications and patent applications known to the interested specialist
> sind. Alle diese Verfahren haben jedoch gemeinsam, dass die> are. However, all of these methods have in common that the
Vorgehensweise zur Eröffnung der Zelle mit extrem aufwendiger Präzisionstechnologie zu erfolgen hat und daher die Kosten für eine Einzelzellimpfung sehr hoch sind.The procedure for opening the cell has to be carried out with extremely complex precision technology and therefore the costs for a single cell vaccination are very high.
Erfindungsgemäße Lösung Erfindungsgemäß sollen daher ein Verfahren und eine Vorrichtung entwickelt werden, die es ermöglicht, einzelne Zellen oder Zellensembles bis hin zu Gewebeverbänden möglichst einfach mit hoher Effizienz mit dem gewünschten biologischen oder pharmakologischen Material zu impfen. Überraschenderweise hat sich gezeigt, dass es möglich ist, durch lokal induzierte Ultraschallschwingungen die Zellmembranen derart zu beeinflussen, dass sie unter Einfluss eben dieser Ultraschalleinwirkung durchlässiger werden und insbesondere einzelne natürlicherweise vorhandene Poren so weit öffnen, dass in der Umgebung der Zelle vorliegendes biologisches oder pharmakologisches Material in die Zelle eindringen kann. Insbesondere wird dieser Vorgang in der Gegenwart von Kavitation bevorzugt. Es hat sich nun auch für den Fachmann völlig überraschend gezeigt, dass es möglich ist, mit geeignet dimensionierten, flexiblen Glasfasern bzw. ' Faserbündeln Ultraschallschwingungen im Frequenzbereich über 20 kHz im Grundsatz bis zu einigen 50 MHz weiterzuleiten und dass abhängig von der Viskosität der Umgebung der Faserspitze es bei Ultraschallfrequenzen zwischen 20 und 100 kHz zu Kavitationen kommen kann, wobei die entstehende Kavitationsdynamik den Vorgang der Einschleusung von biologischem und pharmakologischem Material in die im Schallfeld vorhandenen Zellen unterstützt und im Grundsatz überhaupt erst möglich macht.Solution According to the Invention According to the invention, therefore, a method and a device are to be developed which make it possible to inoculate individual cells or cell ensembles up to tissue clusters with the desired biological or pharmacological material with high efficiency as simply as possible. Surprisingly, it has been shown that it is possible to influence the cell membranes by means of locally induced ultrasonic vibrations in such a way that they become more permeable under the influence of precisely this ultrasound effect and in particular open individual naturally existing pores to such an extent that biological or pharmacological material present in the vicinity of the cell can penetrate into the cell. In particular, this process is preferred in the presence of cavitation. It has now been found, very surprisingly, also for the skilled person that it is possible dimensioned with suitable, flexible glass fiber or 'fiber bundles ultrasonic vibrations in the frequency range above 20 kHz in principle to several forward 50 MHz and that depending on the viscosity of the environment of the Fiber tip, cavitation can occur at ultrasound frequencies between 20 and 100 kHz, the resulting cavitation dynamics supporting the process of introducing biological and pharmacological material into the cells present in the sound field and in principle making it possible in the first place.
In einem ersten Ausführungsbeispiel werden dabei ein oder mehrere einzelne ultraschallführende Glasfasern in eine Suspension aus Zellen
und in Lösung befindlichem Impfmaterial eingeführt und über geeignet angekoppelte elektrische oder magnetostriktive Ultraschallgeber angeregt. Als besonders geeignet hat sich eine Anordnung aus einem piezoelektrischen Verbundwandler erwiesen, der zusammen mit der Glasfaser beziehungsweise dem Faserbündel ein akustisches System bildet, das in Resonanz angeregt wird. Die Schalleinkopplung in die Glasfaser beziehungsweise das Faserbündel erfolgt vorteilhaft durch eine mechanische Verbindung wie Kleben oder Klemmen in einem Punkt, an dem die Amplitude der mechanischen Spannung minimal ist (Spannungsknoten). Die Glasfaser beziehungsweise das Faserbündel muss in diesem Fall ein Vielfaches der halben Wellenlänge lang sein. Da der Prozess der transmembranen Impfung von Zellen besonders effektiv im Bereich der Einsatzschwelle der Kavitationsbildung ist, befindet sich im akustischen System ein Ultraschallaufnehmer, der über die rückgekoppelte Messung des sich ausbildenden Ultraschallstehwellenfeldes den Einsatzpunkt der distal auftretenden Kavitation erkennt und danach Amplitude und ggf. Frequenz des Schwingers rückgekoppelt steuert. In Weiterführung des Erfindungsgedankens kann das Verfahren zur Impfung einzelner Zellen oder Zellverbände auch für medizinische Anwendungen der Gestalt benutzt werden, dass über einen Führungskatheter Impfmaterial in die Zielregion eines biologischen Gewebes eingeführt wird und über ebendiesen Katheter bzw. einen zweiten Zugang die ultraschallführende Glasfaser eingeführt wird und sodann in der zu behandelnden Zielregion ein Ultraschallfeld im Einsatzbereich der Kavitation aufgebaut wird, um damit eine beschleunigte Impfung des Zielgewebematerials auf zellulärer Ebene mit biologisch/gentechnischem bzw. pharmakologischem Material zu fördern.In a first exemplary embodiment, one or more individual ultrasound-guiding glass fibers are in a suspension of cells and vaccine material in solution is introduced and excited via suitably coupled electrical or magnetostrictive ultrasound transmitters. An arrangement consisting of a piezoelectric composite transducer has proven to be particularly suitable, which together with the glass fiber or the fiber bundle forms an acoustic system which is excited in resonance. The sound coupling into the glass fiber or the fiber bundle is advantageously carried out by a mechanical connection such as gluing or clamping at a point where the amplitude of the mechanical tension is minimal (tension node). In this case, the glass fiber or the fiber bundle must be a multiple of half the wavelength. Since the process of transmembrane vaccination of cells is particularly effective in the area of the application threshold of cavitation formation, there is an ultrasound transducer in the acoustic system, which detects the application point of the distal cavitation via the feedback measurement of the developing ultrasound standing wave field and then the amplitude and frequency of the Schwingers feedback controls. In a continuation of the inventive concept, the method for vaccinating individual cells or cell assemblies can also be used for medical applications in such a way that vaccine material is introduced into the target region of a biological tissue via a guide catheter and the ultrasound-guiding glass fiber is introduced via this catheter or a second access and an ultrasound field is then built up in the area of application of the cavitation in the target region to be treated, in order to promote an accelerated vaccination of the target tissue material at the cellular level with biological / genetic engineering or pharmacological material.
In den Figuren 1 und 2 ist das Prinzip der erfindungsgemäßen Vorrichtung näher erläutert. Dabei zeigt Figur 1 ein Ausführungsbeispiel bestehend aus einem Ultraschallwandler 2 mit einer Einrichtung 3 zur Messung der Amplitude, die zum Beispiel aus einer zusätzlichen, passiven Piezoscheibe bestehen kann, sowie der mechanischen Ankopplung 4 der Glasfaser 5. Der Ultraschallwandler 2 wird durch den elektrischen Ultraschallgenerator 1 angetrieben, der gleichzeitig das Signal der Messeinrichtung 3 auswertet und die Frequenz und Amplitude im Sinne einer optimalen Wirkung regelt. Das distale Ende der Faser 5 befindet sich in der Suspension 7 aus den Zellen und dem in Lösung befindlichem Impfmaterial, die sich in dem Reaktionsgefäß 6 befindet. Die durch den Ultraschall entsehenden Kavitationseffekte 8 in der Suspension 7 ermöglichen beziehungsweise unterstützen die Einschleusung des biologischen und oder pharmakologischen Materials in die Zellen.The principle of the device according to the invention is explained in more detail in FIGS. 1 and 2. 1 shows an exemplary embodiment consisting of an ultrasound transducer 2 with a device 3 for measuring the amplitude, which may consist, for example, of an additional, passive piezo disk, and the mechanical coupling 4 of the glass fiber 5. The ultrasound transducer 2 is generated by the electric ultrasound generator 1 driven, which simultaneously evaluates the signal of the measuring device 3 and regulates the frequency and amplitude in the sense of an optimal effect. The distal end of the fiber 5 is in the suspension 7 of the cells and the inoculum in solution, which is located in the reaction vessel 6. The cavitation effects 8 caused by the ultrasound in the suspension 7 enable or support the introduction of the biological and or pharmacological material into the cells.
Die Figur 2 zeigt ein Ausführungsbeispiel zur Impfung von Zellen imFIG. 2 shows an embodiment for vaccinating cells in the
Gewebeverband. Dabei überträgt der Ultraschallwandler 10, mit Amplitudenmeßeinrichtung 11 und Ankopplung 12 eineTissue formation. The ultrasound transducer 10 transmits one with an amplitude measuring device 11 and a coupling 12
Ultraschallschwingung auf die flexible Glasfaser 13. Angetrieben wird
der Ultraschallwandler 10 durch den Der Generator 1, der gleichzeitig mit Hilfe des Signals der Meßeinrichtung 11 die Amplitude und Frequenz auf einen für die Wirkung optimalen Wert regelt. Die Glasfaser 13 führt durch einen Führungskatheter 14 hindurch in das zu behandelnde Gewebeareal 15. Durch den Führungskatheter 14 wird das in Lösung befindliche zu impfende biologische beziehungsweise pharmakologische Material injiziert 16, das durch die Ultraschalleffekte 17 in die Zellen eindringen kann.
Ultrasonic vibration on the flexible glass fiber 13 the ultrasonic transducer 10 by the generator 1, which simultaneously regulates the amplitude and frequency to an optimum value for the effect with the aid of the signal from the measuring device 11. The glass fiber 13 leads through a guide catheter 14 into the tissue area 15 to be treated. The biological or pharmacological material to be inoculated in solution is injected 16 through the guide catheter 14, which material can penetrate into the cells through the ultrasound effects 17.
Claims
1. Verfahren und Vorrichtung zur ultraschallgestützten Impfung von Zellen, dadurch gekennzeichnet, dass die Ultraschallenergie über geeignet geformte Glasfasern in die unmittelbare Nähe der zu impfenden Zellen in einem das Impfmedium tragenden Fluid gebracht wird. 1. The method and device for ultrasound-assisted inoculation of cells, characterized in that the ultrasound energy is brought into the immediate vicinity of the cells to be vaccinated in a fluid carrying the inoculation medium via suitably shaped glass fibers.
2. Verfahren und Vorrichtung nach 1 dadurch gekennzeichnet, dass an der ultraschallführenden Faser ein Messsystem zur Erkennung des Einsetzens der Kavitation durch Ultraschallimpedanzmessung angebracht ist. 2. The method and device according to 1, characterized in that a measuring system for detecting the onset of cavitation by ultrasonic impedance measurement is attached to the ultrasonic fiber.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10108799 | 2001-02-19 | ||
DE10108799A DE10108799A1 (en) | 2001-02-19 | 2001-02-19 | Method and device for the ultrasonic vaccination of biological cell material |
PCT/DE2002/000581 WO2002066597A1 (en) | 2001-02-19 | 2002-02-18 | Method and device for ultrasonic innoculation of biological cell material |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1362091A1 true EP1362091A1 (en) | 2003-11-19 |
Family
ID=7675273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02717954A Withdrawn EP1362091A1 (en) | 2001-02-19 | 2002-02-18 | Method and device for ultrasonic innoculation of biological cell material |
Country Status (4)
Country | Link |
---|---|
US (1) | US20060024803A1 (en) |
EP (1) | EP1362091A1 (en) |
DE (1) | DE10108799A1 (en) |
WO (1) | WO2002066597A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10108798A1 (en) * | 2001-02-19 | 2002-09-26 | Laser & Med Tech Gmbh | Method and device for ultrasound-supported transmembrane medication application in vivo |
DE10223196B4 (en) * | 2002-05-24 | 2004-05-13 | Dornier Medtech Systems Gmbh | Method and device for transferring molecules into cells |
US7704743B2 (en) | 2005-03-30 | 2010-04-27 | Georgia Tech Research Corporation | Electrosonic cell manipulation device and method of use thereof |
DE102007004856A1 (en) | 2007-01-31 | 2008-08-07 | Universität Wien | Pipette device, manipulation device and method for manipulating biological cells |
CN105176796B (en) * | 2015-09-28 | 2018-02-02 | 苏州大学 | The vibratory equipment of cell culture fluid |
US11053473B2 (en) * | 2019-06-25 | 2021-07-06 | Hemex Health, Inc. | External sonication |
CN112899158B (en) * | 2021-01-15 | 2022-08-05 | 深圳康沃先进制造科技有限公司 | Micro-processing gas matching layer modulation body ultrasonic cell assembling and arranging device, preparation method and application |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2578505A (en) * | 1948-03-02 | 1951-12-11 | Sperry Prod Inc | Supersonic agitation |
US2707391A (en) * | 1951-10-23 | 1955-05-03 | Bell Telephone Labor Inc | Testing viscous liquids |
US3406302A (en) * | 1966-03-15 | 1968-10-15 | Westinghouse Electric Corp | Cylindrical magnetostrictive electromechanical transducer |
DE2346649A1 (en) * | 1973-09-17 | 1975-03-27 | Ngk Spark Plug Co | Ultrasonic generator - reflecting radially inwardly direct ultrasonic waves with electromechanical transducer around outside of metal ring |
US4369100A (en) * | 1977-09-27 | 1983-01-18 | Sawyer Harold T | Method for enhancing chemical reactions |
GB2027539B (en) * | 1978-08-09 | 1983-09-21 | Marconi Co Ltd | Measurement of the density of liquids |
EP0068961A3 (en) * | 1981-06-26 | 1983-02-02 | Thomson-Csf | Apparatus for the local heating of biological tissue |
FR2563725B1 (en) * | 1984-05-03 | 1988-07-15 | Dory Jacques | APPARATUS FOR EXAMINING AND LOCATING ULTRASONIC TUMORS WITH A LOCALIZED HYPERTHERMAL TREATMENT DEVICE |
US6203777B1 (en) * | 1983-12-21 | 2001-03-20 | Nycomed Imaging As | Method of contrast enhanced magnetic resonance imaging using carbohydrate particles |
US4620546A (en) * | 1984-06-30 | 1986-11-04 | Kabushiki Kaisha Toshiba | Ultrasound hyperthermia apparatus |
US4671254A (en) * | 1985-03-01 | 1987-06-09 | Memorial Hospital For Cancer And Allied Diseases | Non-surgical method for suppression of tumor growth |
US5542935A (en) * | 1989-12-22 | 1996-08-06 | Imarx Pharmaceutical Corp. | Therapeutic delivery systems related applications |
US6088613A (en) * | 1989-12-22 | 2000-07-11 | Imarx Pharmaceutical Corp. | Method of magnetic resonance focused surgical and therapeutic ultrasound |
IN172208B (en) * | 1990-04-02 | 1993-05-01 | Sint Sa | |
NO912922L (en) * | 1990-09-05 | 1992-03-06 | Atochem North America | PEROXIDES FOR POLYMERIZATION REACTIONS. |
EP0539660B1 (en) * | 1991-10-30 | 1997-05-28 | Fuhrberg Teichmann Windolph Lisa Laser Products Ohg | Process of micromanipulation and apparatus with utilization for in vitro fertilization |
US5524620A (en) * | 1991-11-12 | 1996-06-11 | November Technologies Ltd. | Ablation of blood thrombi by means of acoustic energy |
US5362309A (en) * | 1992-09-14 | 1994-11-08 | Coraje, Inc. | Apparatus and method for enhanced intravascular phonophoresis including dissolution of intravascular blockage and concomitant inhibition of restenosis |
US5318014A (en) * | 1992-09-14 | 1994-06-07 | Coraje, Inc. | Ultrasonic ablation/dissolution transducer |
CN1245156C (en) * | 1993-02-22 | 2006-03-15 | 美国生物科学有限公司 | Methods for in vivo delivery of biologics and compositions useful therefor |
US5665383A (en) * | 1993-02-22 | 1997-09-09 | Vivorx Pharmaceuticals, Inc. | Methods for the preparation of immunostimulating agents for in vivo delivery |
US5650156A (en) * | 1993-02-22 | 1997-07-22 | Vivorx Pharmaceuticals, Inc. | Methods for in vivo delivery of nutriceuticals and compositions useful therefor |
US5665382A (en) * | 1993-02-22 | 1997-09-09 | Vivorx Pharmaceuticals, Inc. | Methods for the preparation of pharmaceutically active agents for in vivo delivery |
DE4309456A1 (en) * | 1993-03-24 | 1994-09-29 | Hoechst Ag | Polyethylene compositions for injection molding |
US5395592A (en) * | 1993-10-04 | 1995-03-07 | Bolleman; Brent | Acoustic liquid processing device |
US5795581A (en) * | 1995-03-31 | 1998-08-18 | Sandia Corporation | Controlled release of molecular components of dendrimer/bioactive complexes |
US6245347B1 (en) * | 1995-07-28 | 2001-06-12 | Zars, Inc. | Methods and apparatus for improved administration of pharmaceutically active compounds |
US6039565A (en) * | 1997-01-14 | 2000-03-21 | Chou; Marilyn M. | Combined ultrasonic and laser device and method of use |
US6416740B1 (en) * | 1997-05-13 | 2002-07-09 | Bristol-Myers Squibb Medical Imaging, Inc. | Acoustically active drug delivery systems |
JP4094118B2 (en) * | 1998-05-21 | 2008-06-04 | 出光興産株式会社 | Gear oil composition |
CA2238951A1 (en) * | 1998-05-26 | 1999-11-26 | Les Technologies Sonomax Inc. | Acoustic cavitation reactor for the processing of materials |
US6298264B1 (en) * | 1998-08-31 | 2001-10-02 | Duke University | Apparatus and method for macromolecule delivery into living cells |
US6428532B1 (en) * | 1998-12-30 | 2002-08-06 | The General Hospital Corporation | Selective tissue targeting by difference frequency of two wavelengths |
US6444192B1 (en) * | 1999-02-05 | 2002-09-03 | The Regents Of The University Of California | Diagnostic imaging of lymph structures |
US6206835B1 (en) * | 1999-03-24 | 2001-03-27 | The B. F. Goodrich Company | Remotely interrogated diagnostic implant device with electrically passive sensor |
US6424863B1 (en) * | 1999-03-26 | 2002-07-23 | Stephen T. Flock | Delivery of pharmaceutical compounds and collection of biomolecules using electromagnetic energy and uses thereof |
DE19945441A1 (en) * | 1999-09-22 | 2001-04-05 | Arimedes Biotechnology Gmbh | Introducing nucleic acids, proteins or peptides into eukaryotic cells comprises exposure to ultrasound or gravitational forces in the presence of an adjuvant comprising calcium and phosphate |
JP2003533974A (en) * | 1999-12-23 | 2003-11-18 | ドルニエル メドテック システムズ ゲーエムベーハー | Equipment for introducing molecules into cells |
US6444217B1 (en) * | 2000-04-25 | 2002-09-03 | University Of Washington | Drug delivery devices, and methods of use |
-
2001
- 2001-02-19 DE DE10108799A patent/DE10108799A1/en not_active Withdrawn
-
2002
- 2002-02-18 EP EP02717954A patent/EP1362091A1/en not_active Withdrawn
- 2002-02-18 WO PCT/DE2002/000581 patent/WO2002066597A1/en active Search and Examination
-
2003
- 2003-08-19 US US10/644,971 patent/US20060024803A1/en not_active Abandoned
Non-Patent Citations (1)
Title |
---|
See references of WO02066597A1 * |
Also Published As
Publication number | Publication date |
---|---|
DE10108799A1 (en) | 2002-09-05 |
US20060024803A1 (en) | 2006-02-02 |
WO2002066597A1 (en) | 2002-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69631555T2 (en) | DEVICE FOR CRUSHING CONCRETE | |
CN109982649B (en) | Method and apparatus for extracting and delivering entities | |
DE69839214T2 (en) | ULTRASONIC WALLER FOR HIGH TRANSDUCTION IN GASES AND METHOD FOR CONTACTLESS ULTRASONIC TRANSMISSION IN SOLID MATERIALS | |
DE69722414T2 (en) | MULTIPLE MECHANICAL MICROPERFORATION OF SKIN OR MUCOSA | |
EP1452141B1 (en) | Shock wave generating device | |
EP0555549A1 (en) | Method and apparatus for high pressure liquid-jet-cutting | |
EP1163882A1 (en) | Intracorporeal lithotripter for removal of calculi | |
WO2002066597A1 (en) | Method and device for ultrasonic innoculation of biological cell material | |
EP1663332B1 (en) | Bioreactor for producing a tissue prosthesis, particularly a heart valve | |
EP0991447A1 (en) | Medical instrument for treating biological tissue | |
WO2001000094A1 (en) | Medical instrument for treating biological tissue and method for transmitting pressure waves | |
WO1991007917A2 (en) | Ultrasonic surgical instrument | |
EP1747818A2 (en) | System and method for generating ultrasonic waves | |
DE112020004711T5 (en) | ULTRASOUND PROBE | |
DE10394286T5 (en) | Apparatus for improved shockwave renal fragmentation (SWL) using a piezoelectric ring assembly (PEAA) shockwave generator in combination with a primary shockwave source | |
WO2009018847A1 (en) | Device and method for detaching cells | |
EP1163884A1 (en) | Intracorporeal lithotripter for removing calculi | |
WO2009109196A1 (en) | System and method for generating ultrasonic waves | |
DE102020134602A1 (en) | Lithotripsy device, lithotripsy system and method of operating a lithotripsy device | |
CN101555450A (en) | Ultrasonic device for realizing inner injection and attraction of single cell or tissue block | |
US11684404B2 (en) | Methods and devices for optoacoustic stimulation | |
WO2020030222A1 (en) | Method for producing microstructures | |
DE3814743A1 (en) | DEVICE FOR RESOLVING CONCRETE IN A BODY CAVE | |
DE112020004001T5 (en) | ULTRASOUND PROBE | |
WO1999025258A1 (en) | Device, preferably to carry out medical punctures, and corresponding method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20030909 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: DORNIER MEDTECH SYSTEMS GMBH |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20061020 |